Opportunity overview
NHS National Proprietary Pharmaceuticals - Intravenous (IV) Fluids, Topical Solutions, Urological Solutions & Gelatins - CM/PHR/25/5727 Period of Framework Agreement: 1 June 2026 to 31 May 2028 with an option or option(s) to extend (at the Authority's discretion) for a period or periods up to a total of 24 months. CM/PHR/25/5727/01 - High Use Lines Regionally Awarded to 1 Supplier CM/PHR/25/5727/02 - Not Regionally Awarded Lines CM/PHR/25/5727/03 - All Lines in Lot 1 and Lot 2, available only to Aseptic Units from any Supplier CM/PHR/25/5727/04 - Added Value Services
Classification
- CPV33600000 — Pharmaceutical products
Lots
- Lot 1 - CM/PHR/25/5727/01£126m
- Lot 2 - CM/PHR/25/5727/02£231m
- Lot 3 - CM/PHR/25/5727/03£126m
- Lot 4 - CM/PHR/25?5727/04£1
Documents and notices
- Procurement termination notice on Find a TenderOpen source ↗
- Tender notice on Find a TenderOpen source ↗
- Tender notice on Find a TenderOpen source ↗
- Preliminary market engagement notice on Find a TenderOpen source ↗